new COX-2 inhibitor called Bextra (valdecoxib)

You'll see a new COX-2 inhibitor called Bextra (valdecoxib).

It'll be co-marketed by Pharmacia and Pfizer...the same companies that market Celebrex (celecoxib).

Bextra is approved for osteoarthritis...rheumatoid arthritis...and dysmenorrhea. It's NOT approved yet for acute pain...but it probably will be after the company submits additional studies to the FDA.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote